Momenta To Pay $35M To Exit Blood Clot Drug Antitrust Suit

By Adam Lidgett · December 11, 2019, 6:41 PM EST

Momenta has agreed to pay $35 million to exit a class action brought by a group of drug buyers accusing the company and Sandoz of conspiring to monopolize the blood clot...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

The Hospital Authority of Metropolitan Government of Nashville and Davidson County, Tennessee v. Momenta Pharmaceuticals, Inc. et al

Case Number

3:15-cv-01100

Court

Tennessee Middle

Nature of Suit

Anti-Trust

Date Filed

October 14, 2015